EVALUASI PEMANTAUAN TERAPI OBAT PADA PASIEN GERIATRI DENGAN TIA, SINDROMA DISPEPSIA, DISLIPIDEMIA, DIABETES MELITUS TIPE 2 DI RUMAH SAKIT “X” DI JAKARTA
Abstract
Pemantauan terapi obat (PTO) dilakukan untuk memastikan keamanan, efektivitas, dan ketepatan penggunaan obat pada pasien. Pelaksanaan pemantauan terapi obat terlihat pada kasus seorang pasien yang datang ke Poli Saraf dengan keluhan tidak ada nafsu makan, bicara pelo, begah, mual, muntah, dan keluarga mengatakan pasien tidak mau makan sejak pulang perawatan dari Unit Stroke. Pasien didiagnosa Transient ischemic attack (TIA), sindroma dispepsia, dislipidemia, dan diabetes melitus tipe 2. Tujuan pemantauan terapi obat adalah untuk mengidentifikasi Drug Related Problems (DRPs) pada pasien geriatri dengan diagnosa Transient ischemic attack (TIA), sindroma dispepsia, dislipidemia, dan diabetes melitus tipe 2. Metode yang dilakukan dalam pemantauan terapi obat ini adalah secara observasional dengan pengambilan data melalui catatan perkembangan pasien terintergrasi dari Sistem Informasi Manajemen Rumah Sakit (SIMRS), analisis data menggunakan format SOAP, identifikasi Drug Related Problems (DRPs) berdasarkan klasifikasi PCNE (Pharmaceutical Care Network Europe) V9.1, dan melakukan visite secara langsung serta koordinasi profesional pemberi asuhan terkait intervensi pengobatan. Berdasarkan pemantauan terapi obat diperoleh drug related problems berupa adanya interaksi obat dengan kategori mayor antara Donepezil HCl dengan Risperidone yang dapat mengakibatkan meningkatnya risiko perpanjangan interval QT dan torsade de pointes. Setiap intervensi telah dicantumkan di catatan perkembangan pasien terintegrasi dan telah didiskusikan dengan dokter sehingga hasil intervensi dapat diimplementasikan.
Kata kunci: Pemantauan terapi obat, Transient ischemic attack, Sindroma dispepsia, Dislipidemia, Diabetes melitus tipe 2
Full Text:
PDF (Bahasa Indonesia)References
Mendelson, S.J., Prabhakaran, S. 2021. Diagnosis and Management of Transient Ischemic Attack and Acute Ischemic Stroke: A Review. JAMA. 325(11): 1088-1098.
Fonseca, A.C., Merwick, Á., Dennis, M., Ferrari, J., Ferro, J.M., Kelly, P., Lal, A., Ois, A., Olivot, J.M., Purroy, F. 2021. European Stroke Organisation (ESO) guidelines on management of transient ischaemic attack. European Stroke Journal. 6(2): CLXIII-CLXXXVI.
Black CJ, et al. 2022. British Society of Gastroenterology guidelines on the management of dyspepsia. Gut. 71(9):1697-1730.
Khairul, A. P., Pranoto, A., & Yusuf, M. 2025. Profile of Dyslipidemia and Type 2 Diabetes Mellitus in Geriatric Inpatients with STEMI in the Department of Cardiology and Vaskular Medicine at a Tertiary Hospital in Surabaya, Indonesia. International Journal of Scientific Advances. 6(1): 230-233.
Cheng, Y.C., Kuo, Y.C., Chang, P.C., Li, Y.C., Huang, W.T., Chen, W., Chou, C.Y. 2021. Geriatric Functional Impairment Using the Integrated Care for Older People (ICOPE) Approach in Community-Dwelling Elderly and Its Association with Dyslipidemia. Vaskular Health and Risk Management. 17: 389-394.
Galicia-Garcia, U., Benito-Vicente, A., Jebari, S., Larrea-Sebal, A., Siddiqi, H., Uribe, K. B., Ostoloza, H. & Martín, C. 2020. Pathophysiology of type 2 diabetes mellitus. International journal of molecular sciences. 21(17): 6275.
Młynarska, E., Czarnik, W., Dzieża, N., Jędraszak, W., Majchrowicz, G., Prusinowski, F., Stabrawa, M., Rysz, J., Franczyk, B. 2025. Type 2 Diabetes Mellitus: New Pathogenetic Mechanisms, Treatment and the Most Important Complications. International Journal Molecular Science. 26(3): 1094.
Mavridis, A., Abzhandadze, T., Viktorisson, A. et al.2024. Physical activity modification following a Transient Ischemic Attack in individuals with diabetes. Cardiovasc Diabetol. 23: 288.
Sumi, H., Tominaga, N., Fujita, Y., Verbalis, J. G., & Electrolyte Winter Seminar Collaborative Group. 2025. Pathophysiology, symptoms, outcomes, and evaluation of hyponatremia: comprehension and best clinical practice. Clinical and Experimental Nephrology. 29: 134-148.
Spasovski, G. 2024. Etiology, Clinical Approach, and Therapeutic Consequences of Hyponatremia. Kidney Dial. 4(1): 37-45.
Spasovski, G. 2024. Hyponatraemia-treatment standard 2024, Nephrology Dialysis Transplantation. 39(10): 1583-1592.
Kim, M.J., Valerio, C., & Knobloch, G.K. 2023. Potassium Disorders: Hypokalemia and Hyperkalemia. American Family Physician. 107(1): 59-70.
Makinouchi R, Machida S, Matsui K, Shibagaki Y, Imai N. 2022. Severe hypokalemia in the emergency department: A retrospective, single-center study. Health Science Reports. 5(3): e594.
Sagar, N., & Lohiya, S. 2024. A Comprehensive Review of Chloride Management in Critically Ill Patients. Cureus, 16(3): e55625.
Riaz, S., Ali, M., Hussain, M., Hassan, Z., Hamidullah, N. A., Ur-Rehman, Z., Ali, S., Ahmed, I., & Shahzad, S. 2025. Prevalence and Clinical Correlates of Hypomagnesemia in Ischemic Stroke Patients: A Single-Center Study From a Tertiary Care Center in Pakistan. Cureus. 17(5): e84742.
Suwała, S., & Junik, R. 2025. Hyperglycemia as the Most Important Risk Factor for Serum Hypomagnesemia in Metabolic Syndrome. Diabetology. 6(8): 82
Hall C, Nagengast AK, Knapp C, Behrens B, Dewey EN, Goodman A, Bommiasamy A, Schreiber M. 2021. Massive transfusions and severe hypocalcemia: An opportunity for monitoring and supplementation guidelines. Transfusion. 61: S188-S1941.
Pompili, E., Zaccherini, G., Baldassarre, M., Iannone, G., Caraceni, P.. 2023. Albumin administration in internal medicine: A journey between effectiveness and futility. European Journal of Internal Medicine. 117: 28-37.
Allison, S.P., Lobo, D.N. 2024. The clinical significance of hypoalbuminaemia. Clinical Nutrition. 43(4): 909-914.
Rommel, A., et al. 2025. Dementia–Prevalence, trends and regional patterns in Germany. An analysis based on routine data from the statutory health insurance. Journal of Health Monitoring. 10(1): e13079.
Javed, S., dan Kakul, F. 2023. Psychological theories of dementia. Journal of Gerontology and Geriatrics. 71: 109-114.
Menkes RI. 2016. Peraturan Menteri Kesehatan Republik Indonesia Nomor 72 Tahun 2016 tentang Standar Pelayanan Kefarmasian di Rumat Sakit. Jakarta: Menteri Kesehatan Republik Indonesia.
Micromedex. 2025. IBM Micromedex Drug Ref (online). Diakses 2025.
Chi, G., Lee, J.J., Montazerin, S.M., and Marszalek, J. 2022. Association of D-dimer with short-term risk of venous thromboembolism in acutely ill medical patients: A systematic review and meta-analysis. Vascular Medicine. 27(5): 478-486.
Perkumpulan Endokrinologi Indonesia (PERKENI). 2021. Panduan Pengelolaan Dislipidemia di Indonesia 2021. Jakarta: PB Perkeni.
Kemenkes RI. 2019. Keputusan Menteri Kesehatan Republik Indonesia Nomor HK.01.07/MENKES/394/2019 Tentang Pedoman Nasional Pelayanan Kedokteran Tata Laksana Stroke.
Perkumpulan Endokrinologi Indonesia (PERKENI). 2021. Pedoman Pengelolaan dan Pencegahan Diabetes Melitus Tipe 2 di Indonesia 2021. Jakarta: PB PERKENI.
Adrogue, H.J., et al. 2022. Diagnosis and Management of Hyponatremia A review. JAMA. 28(3): 280-291.
Angelia, C.L. Hipoalbuminemia: Patofisiologi dan Tata Laksana.Cermin Dunia Kedokteran. 52(8): 521-525.
Perhimpunan Dokter Spesialis Saraf Indonesia (PERDOSSI). 2023. Pedoman Praktik Klinis Neurologi 2023. Jakarta: Perhimpunan Dokter Spesialis Saraf Indonesia.
Gotta, V., Donner, B. 2025. QT interval prolongation: clinical assessment, risk factors and quantitative pharmacological considerations. Journal of Pharmacokinetics and Pharmacodynamics. 52: 61.
DOI: https://doi.org/10.52447/scpij.v10i2.9022
Refbacks
- There are currently no refbacks.
.png)





